SCHEMBL6067779

SCHEMBL6067779

Cc1c(C)c(NC(=O)OC(C)(C)C)c(C)c(OCC(=O)O)c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.36
CD69 Q07108 2/20 0.35
HPGD P15428 1/20 0.35
PTPRB P23467 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ELANE P08246 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
HTT P42858 1/20 0.31
CYP17A1 P05093 1/20 0.31
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
CA14 Q9ULX7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5215289 0.97 ATR (0.37) ATRCD69HPGDPTPRBHSD17B10
SCHEMBL5216310 0.93 ATR (0.36) ATRCD69HPGDPTPRBHSD17B10
SCHEMBL4205939 0.89 ATR (0.40) ATRCD69HPGDPTPRBHSD17B10
SCHEMBL15218656 0.82 ATR (0.35) ATRHPGDHSD17B10SMN1; SMN2TSHR
SCHEMBL4199622 0.80 HPGD (0.45) ATRCD69HPGDPTPRBHSD17B10
SCHEMBL4207056 0.79 ATR (0.36) ATRPTGDR2KMT2AMEN1GAA
SCHEMBL5213633 0.78 ATR (0.35) ATRPTGDR2KMT2AMEN1GAA
SCHEMBL4202884 0.77 CD69 (0.39) CD69HPGDPTPRBHSD17B10ELANE
SCHEMBL5214170 0.75 ATR (0.35) ATRKMT2AMEN1GAACA12
SCHEMBL2838331 0.74 ATR (0.39) ATRHPGDPTPRBHSD17B10PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067533-B2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. (JP) 2006-06-27 US disclosed
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2003-07-24 US disclosed
EP-1228367-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2002-08-07 EP disclosed
WO-2001079170-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2001-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SCN10A, CAMK2A, CAMK2B ATR 3766/4885CD69 4822/4885HPGD 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.